Table 5
 Adverse events in both treatments during follow up
Event
MP
Cy
Urinary tract infections
8
10
Respiratory
4
6
Oropharyngeal candidiasis
0
2
Herpes zoster
0
2
Systemic hypertension
1
0
Hyperglycaemia
1
0
Pancreatitis
1
0
Death
1
3